Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline Variants
Author:
Affiliation:
1. Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Link
https://jamanetwork.com/journals/jamaoncology/articlepdf/2791557/jamaoncology_terrero_2022_ld_220004_1661975716.80963.pdf
Reference6 articles.
1. Molecular profiling of patients with pancreatic cancer: initial results from the Know Your Tumor initiative.;Pishvaian;Clin Cancer Res,2018
2. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer.;Golan;N Engl J Med,2019
3. Pan-cancer analysis of BRCA1 and BRCA2 genomic alterations and their association with genomic instability as measured by genome-wide loss of heterozygosity.;Sokol;JCO Precis Oncol,2020
4. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.;Strickland;Oncotarget,2016
5. Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial.;O’Reilly;JAMA Oncol,2019
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept;Journal of Experimental & Clinical Cancer Research;2024-01-02
2. An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer;Expert Opinion on Pharmacotherapy;2024-01-02
3. Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction;Cancers;2023-12-19
4. The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy;The Lancet Gastroenterology & Hepatology;2023-12
5. Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma;Journal of Clinical Oncology;2023-11-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3